| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effects of intensive glucose lowering in type 2 diabetes.
|
N Engl J Med
|
2008
|
47.90
|
|
2
|
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
|
N Engl J Med
|
2008
|
38.76
|
|
3
|
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.
|
N Engl J Med
|
2003
|
35.39
|
|
4
|
Glucose control and vascular complications in veterans with type 2 diabetes.
|
N Engl J Med
|
2008
|
25.70
|
|
5
|
Continuous glucose monitoring and intensive treatment of type 1 diabetes.
|
N Engl J Med
|
2008
|
17.19
|
|
6
|
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
|
JAMA
|
2006
|
11.78
|
|
7
|
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.
|
JAMA
|
2001
|
8.80
|
|
8
|
KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease.
|
Am J Kidney Dis
|
2007
|
8.79
|
|
9
|
Adiponectin and adiponectin receptors.
|
Endocr Rev
|
2005
|
8.46
|
|
10
|
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
|
Circulation
|
2000
|
7.37
|
|
11
|
Mean amplitude of glycemic excursions, a measure of diabetic instability.
|
Diabetes
|
1970
|
6.68
|
|
12
|
Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.
|
J Clin Invest
|
2007
|
5.38
|
|
13
|
The effect of continuous glucose monitoring in well-controlled type 1 diabetes.
|
Diabetes Care
|
2009
|
4.93
|
|
14
|
Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
|
Diabetes
|
2008
|
4.05
|
|
15
|
Quantifying temporal glucose variability in diabetes via continuous glucose monitoring: mathematical methods and clinical application.
|
Diabetes Technol Ther
|
2005
|
3.84
|
|
16
|
Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring.
|
Diabetes Care
|
2003
|
3.08
|
|
17
|
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
|
Circulation
|
1999
|
2.90
|
|
18
|
The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.
|
Arch Intern Med
|
1997
|
2.88
|
|
19
|
A novel approach to continuous glucose analysis utilizing glycemic variation.
|
Diabetes Technol Ther
|
2005
|
2.74
|
|
20
|
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.
|
Diabetes
|
2002
|
2.73
|
|
21
|
1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
|
Diabetes Care
|
2006
|
2.44
|
|
22
|
The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport.
|
Proc Natl Acad Sci U S A
|
2004
|
2.39
|
|
23
|
Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.
|
Circulation
|
2004
|
2.22
|
|
24
|
Statistical tools to analyze continuous glucose monitor data.
|
Diabetes Technol Ther
|
2009
|
2.12
|
|
25
|
Comment on: American Diabetes Association. Standards of medical care in diabetes--2011. Diabetes Care 2011;34(Suppl. 1):S11-S61.
|
Diabetes Care
|
2011
|
1.95
|
|
26
|
New and improved methods to characterize glycemic variability using continuous glucose monitoring.
|
Diabetes Technol Ther
|
2009
|
1.95
|
|
27
|
Beyond hemoglobin A1c--need for additional markers of risk for diabetic microvascular complications.
|
JAMA
|
2010
|
1.69
|
|
28
|
Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes--the 'dead in bed' syndrome revisited.
|
Diabetologia
|
2008
|
1.57
|
|
29
|
Time to abandon microalbuminuria?
|
Kidney Int
|
2006
|
1.56
|
|
30
|
Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia.
|
Diabetes
|
2003
|
1.50
|
|
31
|
Post-meal glucose peaks at home associate with carotid intima-media thickness in type 2 diabetes.
|
J Clin Endocrinol Metab
|
2008
|
1.49
|
|
32
|
Insulin as an anti-inflammatory and antiatherogenic modulator.
|
J Am Coll Cardiol
|
2009
|
1.43
|
|
33
|
Blood glucose monitoring technology: translating data into practice.
|
Endocr Pract
|
2004
|
1.40
|
|
34
|
Combined statin and niacin therapy remodels the high-density lipoprotein proteome.
|
Circulation
|
2008
|
1.38
|
|
35
|
Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway.
|
J Biol Chem
|
2010
|
1.19
|
|
36
|
Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects.
|
Circulation
|
2005
|
1.16
|
|
37
|
Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
|
J Clin Invest
|
1983
|
1.12
|
|
38
|
Thromboxane, prostacyclin and isoprostanes: therapeutic targets in atherogenesis.
|
Trends Pharmacol Sci
|
2005
|
1.09
|
|
39
|
Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging.
|
Mol Cell Biol
|
2002
|
1.09
|
|
40
|
Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy.
|
Nephron
|
2000
|
1.03
|
|
41
|
Low clusterin levels in high-density lipoprotein associate with insulin resistance, obesity, and dyslipoproteinemia.
|
Arterioscler Thromb Vasc Biol
|
2010
|
0.96
|
|
42
|
Sustained astrocytic clusterin expression improves remodeling after brain ischemia.
|
Neurobiol Dis
|
2006
|
0.95
|
|
43
|
Glycaemic variability and inflammation in subjects with metabolic syndrome.
|
Acta Diabetol
|
2008
|
0.85
|
|
44
|
Intermittent high glucose exacerbates the aberrant production of adiponectin and resistin through mitochondrial superoxide overproduction in adipocytes.
|
J Mol Endocrinol
|
2010
|
0.84
|
|
45
|
Design of FLAT-SUGAR: Randomized Trial of Prandial Insulin Versus Prandial GLP-1 Receptor Agonist Together With Basal Insulin and Metformin for High-Risk Type 2 Diabetes.
|
Diabetes Care
|
2015
|
0.75
|